Remix Therapeutics logo

Remix Therapeutics

Small molecule therapies designed to reprogram RNA processing

2

Funding Rounds

$151.0m

Money raised

Overview

Small molecule therapies designed to reprogram RNA processing

Funding series

Funding Series Analysis

The company Remix Therapeutics has raised a total of $70m in funding over 2 rounds.

Key Insights:

  • Remix Therapeutics Series B round, May 2022: $70m
  • Remix Therapeutics Series A round December 2020: $81m
Remix Therapeutics logo
Remix Therapeutics Series B round, May 2022 $70m
Remix Therapeutics logo
Remix Therapeutics Series A round December 2020 $81m

Industries

Remix Therapeutics is active in the following industries:
  • Biology
  • Biotechnology
  • Engineering
  • RNA-based and RNA-targeted therapeutics
  • Technology
  • Biomedical engineering